Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study.

Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study.

Item
http://www.wikidata.org/entity/Q34651347
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysisThe next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy responseBRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies.Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studiesBaseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients.Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Germline determinants of clinical outcome of cutaneous melanoma.Monitoring immune responses in the tumor microenvironment.Harnessing the immune system for the treatment of melanoma: current status and future prospects.Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review.Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitorsImmune Checkpoints and Innovative Therapies in Glioblastoma
P2860

Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study.

Item
http://www.wikidata.org/entity/Q34651347
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@ast
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@en
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@nl
type
label
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@ast
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@en
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@nl
prefLabel
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@ast
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@en
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Association of CTLA-4 polymorp ...... TLA-4 blockade: a pilot study.
@en
P2093
P2860
P304
P31
P356
10.3109/07357907.2013.793699
P433
P478
P50
P577
P698